Which has grown faster, MNOV or SERA?

Over the past five years, SERA grew revenue faster — MNOV at a -25.46% CAGR versus SERA at 9.73%.

How have MNOV and SERA total returns compared?

Over the past 5 years, MNOV delivered -13.62% and SERA delivered -28.91% annualized total return. Past performance doesn't predict future results.

MediciNova, Inc. (MNOV) vs Sera Prognostics, Inc. (SERA)

A side-by-side comparison of MediciNova, Inc. and Sera Prognostics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MNOV

MediciNova, Inc.

$82M

$1.67HealthcareDelayed quote: Oct 6, 2026, 2:04 PM EDT

SERA

Sera Prognostics, Inc.

$77M

$2.02HealthcareDelayed quote: Oct 6, 2026, 2:03 PM EDT

Total return — MNOV vs SERA

growth of $100 · dividends reinvested · last 5y

MNOV -54.3% (-14.5%/yr)SERA -83.2% (-30.0%/yr)MNOV compounded faster over this window

MNOV SERA

MNOV vs SERA: by the numbers

•MNOV is the larger company ($82M vs $77M market cap).
•Both run net losses; MNOV's is the smaller (-1168.20% vs -47475.71% net margin).
•SERA grew revenue faster over the past five years (9.73% vs -25.46% CAGR).

Metrics side by side

Valuation

Metric	MNOV	SERA
P/S ratio	89.30	1102.08
P/B ratio	2.21	1.30

Profitability

Metric	MNOV	SERA
Gross margin	7.58%	-102.47%
Operating margin	-3242.47%	-45066.67%
Net margin	-1168.20%	-47475.71%
ROE	-28.85%	-55.97%
ROIC	-31.62%	-59.79%

Growth (annualized)

Metric	MNOV	SERA
Revenue CAGR (5Y)	-25.46%	9.73%
Total return CAGR (5Y)	-13.62%	-28.91%

Frequently asked

Which has grown faster, MNOV or SERA?: Over the past five years, SERA grew revenue faster — MNOV at a -25.46% CAGR versus SERA at 9.73%.
How have MNOV and SERA total returns compared?: Over the past 5 years, MNOV delivered -13.62% and SERA delivered -28.91% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MNOV analysis Full SERA analysis Interactive comparison tool

Dig into the metrics

MediciNova ROE Sera Prognostics ROE MediciNova operating margin Sera Prognostics operating margin MediciNova revenue growth Sera Prognostics revenue growth MediciNova free cash flow Sera Prognostics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.